Neuberger Berman Group »

Takeda Pharmaceutical shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $136k 11k 12.94
2024-03-31 $223k 16k 13.89
2020-03-31 $164k 11k 15.13

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Nvidia Corp Common (NVDA)
Amazon Common (AMZN)
Jpmorgan Chase & Co Common (JPM)
Alphabet Inc-cl C Common (GOOG)
Alphabet Inc Class A A Common (GOOGL)
Eli Lilly & Co Common (LLY)
Berkshire Hathaway Inc Class B Common (BRK.B)
September 24 Puts on SNPS US Option Put Option (SNPS)
Nextera Energy Common (NEE)
T Mobile Us Common (TMUS)
Meta Platforms Inc-class A Common (META)
Procter & Gamble Co/the Common (PG)
Asml Holding Adr Representing Nv Common (ASML)

View all positions for Neuberger Berman Group

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Mondrian Investment Partners
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Renaissance Technologies
First Trust Advisors
Brandes Investment Partners
Van Eck Associates Corp.
BlackRock
Citadel Advisors
Northern Trust
Managed Asset Portfolios
Envestnet Asset Management
BlackRock

View all funds holding Takeda Pharmaceutical